Researchers at the UC Davis Comprehensive Cancer Center are personalizing treatment using tumor xenografts in mice to test and identify more precise treatments for bladder cancer patients.
Ralph de Vere White, MD
Advertisement
Articles by Ralph de Vere White, MD
Advertisement
Latest Updated Articles
Patient-Derived Xenografts Could Improve Precision Medicine OutcomesFebruary 6th 2016
Advertisement
Advertisement
Trending on OncLive
1
Triplet Immunotherapy Regimen Yields Durable Responses in pMMR CRPC
2
FDA-Approved ADCs Prompt the Need for Revisions to the Breast Cancer Management Roadmap
3
Docirbrutinib Yields High Response Rates in MCL and CLL
4
Signatera Is Submitted to Japan's PMDA for Companion Diagnostic Approval in MIBC
5